Serum transthyretin levels in senile systemic amyloidosis: Effects of age, gender and ethnicity

Amyloid

Volumn 15, Issue 4, 2008, Pages 255-261

  Buxbaum, Joel ^a   Koziol, James ^a   Connors, Lawreen H ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Senile systemic amyloidosis; Serum transthyretin; Transthyretin; TTR V122I

Indexed keywords

PREALBUMIN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ALLELE; AMYLOIDOSIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; GENE LOCUS; GENE MUTATION; HEART DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION DYNAMICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENILE AMYLOIDOSIS; SEX DIFFERENCE; SWEDEN; WILD TYPE;

AFRICAN AMERICANS; AGE FACTORS; AGED; ALLELES; AMYLOIDOSIS; AMYLOIDOSIS, FAMILIAL; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART FAILURE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PREALBUMIN; SEX CHARACTERISTICS;

EID: 57449086201     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120802525285     Document Type: Article

References (54)

1. Beneke R, Bonning F. A case of amyloid localized to the heart. Beit Path Anat 1908;44:362-385.
2. Smith RRL, Hutchins GM, Moore GW, Humphrey RL. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloidosis. Am J Med 1979;66:96-104.
3. Pitkanen P, Westermark P, Cornwell GG III. Senile systemic amyloidosis. Am J Pathol 1984;117:391-399.
4. Wright JR, Calkins E. Amyloid in the aged heart: frequency and clinical significance. J Am Geriat Soc 1975;23:97-103.
5. Cornwell GG III, Murdoch WL, Kyle RA, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618-623.
6. Jones RS, Frazier DB. Primary cardiovascular amyloidosis. Its clinical manifestations, pathology, and histogenesis. Arch Pathol 1950;50:366-384.
7. Josselson AJ, Pruitt RD, Edwards IE. Amyloid localized to the heart. Analysis of twenty-nine cases. Arch Pathol 1952;54:359-367.
8. Mulligan LM. Amyloidosis of the heart. Arch Pathol 1958;65:615-630.
9. Buerger L, Braunstein H. Senile cardiac amyloidosis. Am J Med 1960;28:357-367.
10. Hodkinson HM, Pomerance A. The clinical significance of senile cardiac amyloidosis: a prospective clinico-pathological study. Quart J Med 1977;46:381-387.
11. Johansson B, Westermark P. Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991;32:83-92.
12. Olson LJ, Gertz MA, Edwards WD, Li CY, Pellikka PA, Holmes DR Jr., Tajik J, Kyle RA. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 1987;317:738-742.
13. Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clinic Proc 1988;63:552-564.
14. Kaye GC. Isolated atrial amyloid contains atrial natriuretic peptide: a report of six cases. Br Heart J 1986;56:317-320.
15. Johansson B, Wernstedt C, Westermark P. Atrial natriuretic peptide deposited as atrial amyloid fibrils. Biochem Biophys Res Commun 1987;148:1087-1092.
16. Johansson B, Westermark, P. Isolated atrial amyloidosis. Increased frequency in patients with congestive heart failure. In: Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, et al., editors. Amyloid and Amyloidosis 1990. Dordrecht: Kluwer Academic; 1991. p. 474-476.
17. Cornwell GG III, Sletten K, Johansson B, Westermark P. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun 1988;154:648-653.
18. Westermark P, Johansson B, Natvig JB. Senile cardiac amyloidosis: evidence of two different amyloid substances in the aging heart. Scand J Immunol 1979;10:303-308.
19. Kingsbury JS, Theberge R, Karbassi JA, Lim A, Costello CE, Connors LH. Detailed structural analysis of amyloidogenic wild-type transthyretin using a novel purification strategy and mass spectrometry. Anal Chem 2007;79:1990-1998.
20. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. Systemic senile amyloidosis: identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989;83:836-843.
21. Benson MD, Wallace MR, Tejada E, Baumann H, Page B. Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy. Arth Rheum 1987;30:195-200.
22. Dupuy O, Blétry O, Blanc AS, Droz D, Viémont M, Delpech M, Grateau G, A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis. Amyloid 1998;5:285-287.
23. Svendsen IH, Steensgaard-Hansen F, Nordvag BY. A clinical, echocardiographic and genetic characterization of a Danish kindred with familial amyloid transthyretin methionine 111 linked cardiomyopathy [see comments]. Eur Heart J 1998;19:782-789.
24. Westermark P, Sletten K, Johansson B, Cornwell GG III. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843-2845.
25. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999;13:273-279.
26. Myron Johnson A. Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition: international federation of clinical chemistry and laboratory medicine (IFCC): IFCC scientific division committee on plasma proteins (C-PP). Clin Chem Lab Med 2007;45:419-426.
27. Westermark P, Pitkänen P, Benson L, Vahlquist A, Olofsson BO, Cornwell GG III. Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Invest 1985;52:314-318.
28. Felding P, Fex G, Westermark P, Olofsson BO, Pitkänen P, Benson L. Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol 1985;21:133-140.
29. Connors L, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants. Amyloid 2003;10:160-184.
30. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005;165:1425-1429.
31. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Low penetrance of the 845G->A (C282Y) HFE hereditary haemochrmatosis mutation in the United States. Lancet 2002;359:211-218.
32. Van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bull Inst Intern Stat 1960;37:351-361.
33. Kyle RA, Spittell PC, Gertz MA, Li CY, Edwards WD, Olson LJ, Thibodeau SN, The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;101:395-400.
34. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN, Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997;336:466-473.
35. Jacobson DR, Pastore R, Pool S, Malendowicz S, Kane I, Shivji A, Embury SH, Ballas SK, Buxbaum JN, Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 1996;98:236-238.
36. Yamashita T. A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population. Amyloid 2005;12:127-130.
37. Benson MD, Dwulet FE. Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis Rheum 1983;26:1493-1498.
38. Skinner M, Connors LH, Rubinow A, Libbey C, Sipe JD, Cohen AS. Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at risk relatives. Am J Med Sci 1985;289:17-21.
39. Almeida MR, Alves IL, Sakaki Y, Costa PP, Saraiva MJM. Prenatal diagnosis of familial amyloidotic polyneuropathy: evidence for an early expression of the associated transthyretin methionine 30. Hum Genet 1990;85:623-626.
40. Nakazato M, Tanaka M, Yamamura Y, Kurihara T, Matsukura S, Kangawa K, Matsuo H, Abnormal transthyretin in asymptomatic relatives in familial amyloidotic polyneuropathy. Arch Neurol 1987;44:1275-1278.
41. Nakazato M, Kurihara T, Matsukura S, Kangawa K, Matsuo H. Diagnostic radioimmunoassay for familial amyloidotic polyneuropathy before clinical onset. J Clin Invest 1986;77:1699-1703.
42. McEntegart MB. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007;28:829-835.
43. Strassburg S, Anker SD. Metabolic and immunologic derangements in cardiac cachexia: where to from here?Heart fail Rev 2006;11:57-64.
44. Bartalena L, Farsetti A, Flink IL, Robbins J. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells. Mol Endocrinol 1992;6:935-942.
45. Yoshida A. Analysis of the factors contributing to serum retinol binding protein and transthyretin levels in Japanese adults. J Atheroscler Thromb 2006;13:209-215.
46. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 1997;52:M201-M208.
47. Rimessi P, Spitali P, Ando Y, et al. Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point. Liver Int 2006;26:211-220.
48. Mita S. Analyses of prealbumin mRNAs in individuals with familial amyloidotic polyneuropathy. J Biochem 1986;100:1215-1222.
49. Hanes D, Zech LA, Murrell J, Benson MD. Metabolism of normal and MET30 transthyretin. Adv Food Nutr Res 1996;40:149-153.
50. Longo AI, Hays MT, Saraiva MJ. Comparative stability and clearance of [Met30]transthyretin and [Met119]transthyretin. Eur J Biochem 1997;249:662-668.
51. Makover A, Moriwaki H, Ramakrishnan R, Saraiva MJ, Blaner WS, Goodman DS. Plasma transthyretin. Tissue sites of degradation and turnover in the rat. J Biol Chem 1988;263:8598-8603.
52. Sekijima Y, Tokuda T, Kametani F, Tanaka K, Maruyama K, Ikeda S. Serum transthyretin monomer in patients with familial amyloid polyneuropathy. Amyloid 2001;8:257-262.
53. Stangou AJ, Heaton ND, Hawkins PN. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med 2005;352:2356.
54. Wiseman RL, Powers ET, Buxbaum JN, Kelly JW, Balch WE. An adaptable standard for protein export from the endoplasmic reticulum. Cell 2007;131:809-821.